Rockefeller Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,003
Closed -$108K 4745
2025
Q4
$108K Buy
7,003
+904
+15% +$9.96K ﹤0.01% 2687
2025
Q3
$60.6K Buy
+6,099
New +$63.5K ﹤0.01% 2812
2023
Q1
Sell
-20,060
Closed -$213K 2477
2022
Q4
$213K Sell
20,060
-203
-1% -$2.36K ﹤0.01% 1637
2022
Q3
$211K Buy
20,263
+11,566
+133% +$151K ﹤0.01% 1626
2022
Q2
$109K Buy
8,697
+197
+2% +$2.09K ﹤0.01% 1899
2022
Q1
$92K Hold
8,500
﹤0.01% 2020
2021
Q4
$119K Hold
8,500
﹤0.01% 1856
2021
Q3
$163K Buy
+8,500
New +$113K ﹤0.01% 1646
2021
Q1
Sell
-142
Closed 3272
2020
Q4
$0 Buy
+142
New +$643 ﹤0.01% 2884
2020
Q3
Sell
-4,000
Closed -$35K 2627
2020
Q2
$35K Buy
+4,000
New +$20.2K ﹤0.01% 1504

Other funds holding DVAX

Rockefeller Capital Management's DVAX Position: Q1 2026 in Review

Rockefeller Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 7,003 shares — an estimated $108K sold.

Rockefeller Capital Management first reported a position in DVAX in Q2 2020 and held it in 10 quarters. The position peaked at $213K in Q4 2022. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Rockefeller Capital Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 7,003 Dynavax Technologies shares in Q1 2026, an estimated $108K.
  • Rockefeller Capital Management first reported a position in Dynavax Technologies in Q2 2020 and held it in 10 quarters.
  • Rockefeller Capital Management's Dynavax Technologies position peaked at $213K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.